{"id":"https://openalex.org/W3002644153","doi":"https://doi.org/10.3390/cancers12020265","title":"Proteasome Inhibitors for the Treatment of Multiple Myeloma","display_name":"Proteasome Inhibitors for the Treatment of Multiple Myeloma","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-22","ids":{"openalex":"https://openalex.org/W3002644153","doi":"https://doi.org/10.3390/cancers12020265","mag":"3002644153","pmid":"https://pubmed.ncbi.nlm.nih.gov/31979059","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7072336"},"language":"en","primary_location":{"id":"doi:10.3390/cancers12020265","doi":"https://doi.org/10.3390/cancers12020265","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12020265","pdf_url":"https://www.mdpi.com/2072-6694/12/2/265/pdf?version=1580893478","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3002644153"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2072-6694/12/2/265/pdf?version=1580893478","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021620288","display_name":"Shigeki Ito","orcid":"https://orcid.org/0000-0002-3899-6603","observed_orcids":["https://orcid.org/0000-0002-3899-6603"]},"institutions":[{"id":"https://openalex.org/I180680657","display_name":"Iwate Medical University","ror":"https://ror.org/04cybtr86","country_code":"JP","type":"education","lineage":["https://openalex.org/I180680657"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shigeki Ito","raw_affiliation_strings":["Hematology & Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba-cho 028-3695, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology & Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba-cho 028-3695, Japan","institution_ids":["https://openalex.org/I180680657"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021620288"],"corresponding_institution_ids":["https://openalex.org/I180680657"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2324},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2324},"fwci":4.8503,"has_fulltext":true,"cited_by_count":223,"citation_normalized_percentile":{"value":0.97754185,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"12","issue":"2","first_page":"265","last_page":"265"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":1.0},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":1.0},{"id":"https://openalex.org/keywords/ixazomib","display_name":"ixazomib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6389999985694885},{"id":"https://openalex.org/keywords/oral-proteasome-inhibitor","display_name":"oral proteasome inhibitor","score":0.8299999833106995},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.9980000257492065},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8880000114440918},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C2781098529","wikidata":"https://www.wikidata.org/wiki/Q20948663","display_name":"Ixazomib","level":5,"score":0.8860816955566406},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.8596073389053345},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8415423035621643},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.8268771767616272},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.677242636680603},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.6545486450195312},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.6275589466094971},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5674825310707092},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5147900581359863},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4575466513633728},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38477036356925964},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3543025851249695},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3145027160644531},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16022583842277527},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.3390/cancers12020265","doi":"https://doi.org/10.3390/cancers12020265","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12020265","pdf_url":"https://www.mdpi.com/2072-6694/12/2/265/pdf?version=1580893478","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},{"id":"pmid:31979059","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31979059","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7072336","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7072336/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers (Basel)","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3390/cancers12020265","doi":"https://doi.org/10.3390/cancers12020265","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12020265","pdf_url":"https://www.mdpi.com/2072-6694/12/2/265/pdf?version=1580893478","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3002644153.pdf","grobid_xml":"https://content.openalex.org/works/W3002644153.grobid-xml"},"referenced_works_count":91,"referenced_works":["https://openalex.org/W1520916227","https://openalex.org/W1585625390","https://openalex.org/W1654790906","https://openalex.org/W1969648097","https://openalex.org/W1978735501","https://openalex.org/W1980471295","https://openalex.org/W1985864219","https://openalex.org/W1990518937","https://openalex.org/W1991249033","https://openalex.org/W1999153400","https://openalex.org/W1999567975","https://openalex.org/W2009426416","https://openalex.org/W2013370486","https://openalex.org/W2015003025","https://openalex.org/W2020298011","https://openalex.org/W2028330103","https://openalex.org/W2039217634","https://openalex.org/W2039496823","https://openalex.org/W2039723321","https://openalex.org/W2050465851","https://openalex.org/W2055338149","https://openalex.org/W2056236957","https://openalex.org/W2067653691","https://openalex.org/W2068889400","https://openalex.org/W2071430789","https://openalex.org/W2082015682","https://openalex.org/W2088724822","https://openalex.org/W2091362296","https://openalex.org/W2096207943","https://openalex.org/W2099395323","https://openalex.org/W2103289287","https://openalex.org/W2105329712","https://openalex.org/W2106487290","https://openalex.org/W2114217833","https://openalex.org/W2117641259","https://openalex.org/W2119584679","https://openalex.org/W2124560610","https://openalex.org/W2125721471","https://openalex.org/W2128084036","https://openalex.org/W2131394075","https://openalex.org/W2134618140","https://openalex.org/W2138102966","https://openalex.org/W2140493010","https://openalex.org/W2141502099","https://openalex.org/W2142149038","https://openalex.org/W2142368474","https://openalex.org/W2143425592","https://openalex.org/W2146502962","https://openalex.org/W2151595053","https://openalex.org/W2152065071","https://openalex.org/W2156748957","https://openalex.org/W2161160225","https://openalex.org/W2166747788","https://openalex.org/W2170182861","https://openalex.org/W2193716145","https://openalex.org/W2319764074","https://openalex.org/W2343386476","https://openalex.org/W2400276917","https://openalex.org/W2443548094","https://openalex.org/W2489715554","https://openalex.org/W2553693801","https://openalex.org/W2567188480","https://openalex.org/W2588591261","https://openalex.org/W2592937673","https://openalex.org/W2604776612","https://openalex.org/W2611177864","https://openalex.org/W2622381363","https://openalex.org/W2727891259","https://openalex.org/W2737964630","https://openalex.org/W2744127912","https://openalex.org/W2757691238","https://openalex.org/W2772566228","https://openalex.org/W2795030040","https://openalex.org/W2802890120","https://openalex.org/W2805341297","https://openalex.org/W2903109854","https://openalex.org/W2904778784","https://openalex.org/W2905082484","https://openalex.org/W2908048535","https://openalex.org/W2935332994","https://openalex.org/W2945434115","https://openalex.org/W2948728876","https://openalex.org/W2972305086","https://openalex.org/W2973120299","https://openalex.org/W2980189357","https://openalex.org/W2980570729","https://openalex.org/W2992496655","https://openalex.org/W3195431600","https://openalex.org/W4252175385","https://openalex.org/W4254421610","https://openalex.org/W6680277760"],"related_works":["https://openalex.org/W2901917768","https://openalex.org/W2121757574","https://openalex.org/W3087086977","https://openalex.org/W2887253292","https://openalex.org/W2009426416","https://openalex.org/W2052840623","https://openalex.org/W3030367358","https://openalex.org/W2891781364","https://openalex.org/W2773382289","https://openalex.org/W4378528724"],"abstract_inverted_index":{"Use":[0],"of":[1,10,113,132],"proteasome":[2,55],"inhibitors":[3,123],"(PIs)":[4],"has":[5,72],"been":[6,99],"the":[7,14,25,37,64,107,111,126,130],"therapeutic":[8],"backbone":[9],"myeloma":[11],"treatment":[12,131],"over":[13],"past":[15],"decade.":[16],"Many":[17],"PIs":[18],"are":[19],"being":[20],"developed":[21,70],"and":[22,27,40,52,71,76,95,110,120,124],"evaluated":[23],"in":[24,43,58,80,129],"preclinical":[26],"clinical":[28,114],"setting.":[29],"The":[30],"first-in-class":[31],"PI,":[32,49],"bortezomib,":[33],"was":[34,63],"approved":[35],"by":[36],"US":[38],"food":[39],"drug":[41],"administration":[42],"2003.":[44],"Carfilzomib":[45],"is":[46],"a":[47,59,73],"next-generation":[48],"which":[50],"selectively":[51],"irreversibly":[53],"inhibits":[54],"enzymatic":[56],"activities":[57],"dose-dependent":[60],"manner.":[61],"Ixazomib":[62],"first":[65],"oral":[66],"PI":[67],"to":[68],"be":[69],"robust":[74],"efficacy":[75],"favorable":[77],"safety":[78],"profile":[79],"patients":[81],"with":[82,88],"multiple":[83,133],"myeloma.":[84,134],"These":[85],"PIs,":[86],"together":[87],"other":[89],"agents,":[90],"including":[91],"alkylators,":[92],"immunomodulatory":[93],"drugs,":[94],"monoclonal":[96],"antibodies,":[97],"have":[98],"incorporated":[100],"into":[101],"several":[102],"regimens.":[103],"This":[104],"review":[105],"summarizes":[106],"biological":[108],"effects":[109],"results":[112],"trials":[115],"investigating":[116],"PI-based":[117],"combination":[118],"regimens":[119],"novel":[121],"investigational":[122],"discusses":[125],"future":[127],"perspective":[128]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3002644153","counts_by_year":[{"year":2026,"cited_by_count":29},{"year":2025,"cited_by_count":37},{"year":2024,"cited_by_count":35},{"year":2023,"cited_by_count":40},{"year":2022,"cited_by_count":41},{"year":2021,"cited_by_count":34},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2020-01-30T00:00:00"}
